InvestorsHub Logo
Followers 193
Posts 16613
Boards Moderated 10
Alias Born 01/29/2018

Re: Lucky77Dice post# 104893

Monday, 06/22/2020 12:01:05 PM

Monday, June 22, 2020 12:01:05 PM

Post# of 145584
The bad assumption being made is that BioAmber is the only chemical company that can make an agreement with Reverdia, Cargill, Mitsui to use the tech and pay the royalties. BioAmber didn't own the tech, they licensed it and paid royalties to use it.

Here's the agreement:

https://www.sec.gov/Archives/edgar/data/1534287/000156459016014867/bioa-ex1061_303.htm

Reverdia wanted to terminate the agreement as soon as the liquidation started, but PWC told them they couldn't since the judges had issued stays that prevented such actions (that correspondence is attached to the motion to have the agreement assigned to LCYB). PWC then tried to sell the agreements and were unsuccessful. LCYB expressed an interest that PWC even prepared a motion to the courts for, but the courts never acted on it. I don't know this, but I wouldn't be surprised if LCYB played the process to get that motion as leverage to write their own agreement with Reverdia, or their chemists and lawyers looked over everything and concluded they could make the corn sludge and not worry about infringing on that IP.

So, why couldn't LCYB write their own agreement with Reverdia if they wanted to use processes that Reverdia owned?

I swear I’ll never use the phrase “you can’t make this stuff up” ever again after being on the OTC. Apparently you can.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.